DE131552T1 - Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper. - Google Patents

Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper.

Info

Publication number
DE131552T1
DE131552T1 DE198484830195T DE84830195T DE131552T1 DE 131552 T1 DE131552 T1 DE 131552T1 DE 198484830195 T DE198484830195 T DE 198484830195T DE 84830195 T DE84830195 T DE 84830195T DE 131552 T1 DE131552 T1 DE 131552T1
Authority
DE
Germany
Prior art keywords
fraction
sperm
glycoprotein
antigen
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198484830195T
Other languages
German (de)
English (en)
Inventor
Claudia I-00198-Rome Sartori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Istituto Farmacologico Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Farmacologico Serono SpA filed Critical Istituto Farmacologico Serono SpA
Publication of DE131552T1 publication Critical patent/DE131552T1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE198484830195T 1983-06-29 1984-06-27 Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper. Pending DE131552T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48593/83A IT1197670B (it) 1983-06-29 1983-06-29 Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti

Publications (1)

Publication Number Publication Date
DE131552T1 true DE131552T1 (de) 1985-05-09

Family

ID=11267518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE198484830195T Pending DE131552T1 (de) 1983-06-29 1984-06-27 Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper.

Country Status (4)

Country Link
EP (1) EP0131552A3 (https=)
JP (1) JPS6045519A (https=)
DE (1) DE131552T1 (https=)
IT (1) IT1197670B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741998A (en) * 1985-06-05 1988-05-03 The University Of Virginia Alumni Patents Foundation Monoclonal antibody to MHS-5: a new probe for sexual assault analyses
JPS61294366A (ja) * 1985-06-24 1986-12-25 Toubishi Yakuhin Kogyo Kk 糖鎖に特異的な抗体の検出用試薬及びその使用
JP2534480B2 (ja) * 1986-10-16 1996-09-18 晋三 礒島 ヒト精子不動化抗体の対応抗原
JPH0323473U (https=) * 1989-07-12 1991-03-12
EP0410816B1 (en) * 1989-07-28 1998-01-14 Wisconsin Alumni Research Foundation Detection of heparin binding seminal proteins

Also Published As

Publication number Publication date
JPS6045519A (ja) 1985-03-12
IT1197670B (it) 1988-12-06
EP0131552A2 (en) 1985-01-16
IT8348593A1 (it) 1984-12-29
JPS6339573B2 (https=) 1988-08-05
EP0131552A3 (en) 1987-08-12
IT8348593A0 (it) 1983-06-29

Similar Documents

Publication Publication Date Title
DE98204240T1 (de) Verfahren zur Herstellung humanisierter Immunglobuline
DE182442T1 (de) Rekombinante dns-molekuele und verfahren zur herstellung derselben.
PT84427A (de) Hybridinterferone deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3484673D1 (de) Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen.
ATE117900T1 (de) Verfahren zur herstellung nicht modifizierter intravenös verabreichbarer igm- und/oder iga- haltige immunglobulinpräparate.
EP0033000B1 (de) Neues Protein PP15, ein Verfahren zu seiner Herstellung sowie seine Verwendung
DE131552T1 (de) Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper.
EP0009715A1 (de) Neues ubiquitäres Gewebsprotein PP8 und Verfahren zu seiner Anreicherung
EP0100522B1 (de) Neues Protein (PP17), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
AT362477B (de) Verfahren zur herstellung von (u,pu)02-misch- kristallen
DE3306060A1 (de) Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
DE69001623D1 (de) Verfahren zur herstellung von fluor-oxy-fluorsulfonylverbindungen durch direkte fluorierung von fluor-beta-sultonen.
EP0037963A2 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE163141T1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
EP0113040A3 (de) Verfahren zur Reinigung und Fraktionierung von Heparin
DE2616984A1 (de) Verfahren zur anreicherung eines plazentenspezifischen glycoproteins
EP0141326A2 (de) Neues Protein PP20, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE3750664T2 (de) Throminbindende Substanz und Verfahren zu ihrer Herstellung.
DE3410694C2 (https=)
AT367739B (de) Verfahren zur herstellung von 2',6'-dialkyl-n(alkoxymethyl)-2-chloracetaniliden
EP0029191A1 (de) Neues Protein PP11, ein Verfahren zu seiner Gewinnung und seine Verwendung
AT370674B (de) Verfahren zur herstellung von monoaxial verstreckten folien aus polytetrafluoraethylen
DE2718325A1 (de) Leucinreiches 3,1-s-alpha tief 2 -glykoprotein, verfahren zu dessen herstellung sowie dessen verwendung
EP0137345B1 (de) Membranassoziierte Proteine (MP2), Verfahren zu ihrer Gewinnung sowie ihre Verwendung
PT75560B (de) Verfahren zur herstellung von fertigteilen aus hochlegierten ferritischen werkstoffen